# Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real‐world patients

**Authors:** Claudia Bellofiore, Marco Basset, Mario Nuvolone, Martina Nanci, Giuseppe D. Sanna, Valeria A. Di Simone, Alessandro Fogliani, Monica Di Cecca, Roberta Mussinelli, Andrea Foli, Matin Ghazi Esfahani, Mohammadjavad Sadrzadeh, Stefano Perlini, Leonardo De Luca, Solène Clavreul, Giampaolo Merlini, Giovanni Palladini, Paolo Milani

PMC · DOI: 10.1002/hem3.70320 · 2026-02-16

## Full-text entities

- **Diseases:** AL amyloidosis (MESH:D000075363)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12908192/full.md

---
Source: https://tomesphere.com/paper/PMC12908192